Literature DB >> 28963273

Advances in the Treatment of Rheumatoid Arthritis: Costs and Challenges.

David S Pisetsky1.   

Abstract

Rheumatoid arthritis is the most common form of inflammatory arthritis. Because of advances in therapy, clinical outcomes have improved dramatically and remission is possible for many patients. These advances have come with many challenges, prompting consideration of strategies to improve diagnosis and treatment and implement more cost-effective care. ©2017 by the North Carolina Institute of Medicine and The Duke Endowment. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28963273     DOI： 10.18043/ncm.78.5.337

Source DB:  PubMed          Journal:  N C Med J        ISSN： 0029-2559


  12 in total

Review 1.  Effect of vitamin E supplementation in rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Rui Zhang; Jianbing Ma; Haiyang Kou; Zhong Qing; Hao Guo
Journal:  Eur J Clin Nutr       Date:  2022-04-25       Impact factor: 4.016

2.  Use of Network Pharmacology to Investigate the Mechanism of the Compound Xuanju Capsule in the Treatment of Rheumatoid Arthritis.

Authors:  Wenyang Wei; Wanpeng Lu; Xiaolong Chen; Yunfeng Yang; Mengkai Zheng
Journal:  Biomed Res Int       Date:  2021-08-10       Impact factor: 3.411

3.  Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis.

Authors:  Dan Zhang; Jin-Tao Lyu; Bing Zhang; Xiao-Meng Zhang; Hao Jiang; Zhi-Jian Lin
Journal:  BMC Complement Med Ther       Date:  2020-07-06

Review 4.  The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets.

Authors:  Benjamin J Buckley; Umar Ali; Michael J Kelso; Marie Ranson
Journal:  Curr Drug Targets       Date:  2019       Impact factor: 3.465

5.  Antibodies to synthetic citrullinated peptide epitope correlate with disease activity and flares in rheumatoid arthritis.

Authors:  Sangita Khatri; Jonas Hansen; Kira Astakhova
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

Review 6.  Rheumatiod Arthritis: An Updated Overview of Latest Therapy and Drug Delivery.

Authors:  Disha Kesharwani; Rishi Paliwal; Trilochan Satapathy; Swarnali Das Paul
Journal:  J Pharmacopuncture       Date:  2019-12-31

7.  Blood MALT1, Th1, and Th17 cells are dysregulated, inter-correlated, and correlated with disease activity in rheumatoid arthritis patients; meanwhile, MALT1 decline during therapy relates to treatment outcome.

Authors:  Zhuang Ye; Lu Chen; Ying Fang; Ling Zhao
Journal:  J Clin Lab Anal       Date:  2021-11-17       Impact factor: 2.352

8.  Efficacy of methotrexate and etanercept biosimilar rhTNFR:Fc in Chinese patients with active rheumatoid arthritis: A controlled, randomized and multicenter study.

Authors:  Qingjun Wu; Yan Zhao; Dong Xu; Zhuoli Zhang; Zhenbin Li
Journal:  Sci Rep       Date:  2020-08-31       Impact factor: 4.379

9.  Myrtenal and β-caryophyllene oxide screened from Liquidambaris Fructus suppress NLRP3 inflammasome components in rheumatoid arthritis.

Authors:  Wen-Xuan Li; Ping Qian; Yi-Tong Guo; Li Gu; Jessore Jurat; Yang Bai; Dong-Fang Zhang
Journal:  BMC Complement Med Ther       Date:  2021-09-28

10.  KDM4B Overexpression Promotes the Growth, Migration, and Invasion of Rheumatoid Arthritis Fibroblast-Like Synoviocytes by Activating STAT3 Pathway.

Authors:  Xin Zhang; He Nan; Jialong Guo; Jinyu Liu
Journal:  Biochem Genet       Date:  2021-04-28       Impact factor: 1.890
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.